|
|
||||||||
1Department of Cardiology and Endocrinology, Frederiksberg University Hospital, Frederiksberg; and Departments of 3Anesthesiology, 2Hepatology, and 4Cardiology and 5The Copenhagen Muscle Research Center, Copenhagen University Hospital, Copenhagen, Denmark
Submitted 30 May 2005 ; accepted in final form 18 July 2005
Renal metabolism of the cardiac marker NH2-terminal-pro-brain natriuretic peptide (NT-proBNP) has been suggested. Therefore, we determined the renal extraction ratios of NT-proBNP and its bioactive coproduct brain natriuretic peptide (BNP) at rest and during exercise. In addition, the cerebral ratios were evaluated. Ten young healthy men were investigated at baseline, during moderate cycle exercise (heart rate: 140, Borg scale: 1415), and in the recovery with BNP and NT-proBNP measured from the brachial artery and the jugular and renal veins, and the renal and cerebral extraction ratios (Ext-Ren and Ext-Cer, respectively) were calculated. Cardiac output, stroke volume, heart rate, mean arterial pressures, and estimated glomerular filtration were determined. BNP and NT-proBNP were extracted by the kidneys but not by the brain. We observed no effect of exercise. The mean values (± SE) of Ext-Ren of NT-proBNP were similar (0.19 ± 0.05, 0.21 ± 0.06, and 0.12 ± 0.03, respectively) during the three sessions (P > 0.05). Also the Ext-Ren of BNP were similar (0.18 ± 0.07, 0.15 ± 0.11, and 0.14 ± 0.06, respectively; P > 0.05). There were no significant differences between Ext-Ren of BNP and NT-proBNP during the three sessions (P > 0.05). The Ext-Cer of both peptides varied insignificantly between 0.21 ± 0.15 and 0.11 ± 0.08. The renal extraction ratio of both BNP and NT-proBNP is
0.150.20. There is no cerebral extraction, and short-term moderate exercise does not affect these values. Our findings suggest that the kidneys extract BNP and NT-proBNP to a similar extent in healthy young men.
brain natriuretic peptide; NH2-terminal-pro-brain natriuretic peptide; renal extraction ratio
This article has been cited by other articles:
![]() |
G. C.M. Linssen, K. Damman, H. L. Hillege, G. Navis, D. J. van Veldhuisen, and A. A. Voors Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure Circulation, July 7, 2009; 120(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R.J. van Kimmenade, J. L. Januzzi Jr, J. A. Bakker, A. J. Houben, R. Rennenberg, A. A. Kroon, H. J.G.M. Crijns, M. P. van Dieijen-Visser, P. W. de Leeuw, and Y. M. Pinto Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J. Am. Coll. Cardiol., March 10, 2009; 53(10): 884 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Palmer and A. M. Richards Does renal clearance differ between the B-type natriuretic peptides (BNP versus NT-proBNP)? J. Am. Coll. Cardiol., March 10, 2009; 53(10): 891 - 892. [Full Text] [PDF] |
||||
![]() |
S. Vickery, M. C. Webb, C. P. Price, R. I. John, N. A. Abbas, and E. J. Lamb Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3546 - 3553. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Secher, T. Seifert, and J. J. Van Lieshout Cerebral blood flow and metabolism during exercise: implications for fatigue J Appl Physiol, January 1, 2008; 104(1): 306 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. deFilippi, S. L. Seliger, S. Maynard, and R. H. Christenson Impact of Renal Disease on Natriuretic Peptide Testing for Diagnosing Decompensated Heart Failure and Predicting Mortality Clin. Chem., August 1, 2007; 53(8): 1511 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Choi, D. Park, S. Lee, Y. Hong, S. Kim, and J. Lee Cut-off values of B-type natriuretic peptide for the diagnosis of congestive heart failure in patients with dyspnoea visiting emergency departments: a study on Korean patients visiting emergency departments Emerg. Med. J., May 1, 2007; 24(5): 343 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Januzzi, D. M. Lloyd-Jones, and S. Anwaruddin Reply J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1061 - 1061. [Full Text] [PDF] |
||||
![]() |
S. Masson, R. Latini, I. S. Anand, T. Vago, L. Angelici, S. Barlera, E. D. Missov, A. Clerico, G. Tognoni, J. N. Cohn, et al. Direct Comparison of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in a Large Population of Patients with Chronic and Symptomatic Heart Failure: The Valsartan Heart Failure (Val-HeFT) Data Clin. Chem., August 1, 2006; 52(8): 1528 - 1538. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |